According to Director Ohara, the many functions of the bank start to suffer from decreasing funding. The cell bank is a combination of 5 biobanks bio-bank, 1. JCRB cell bank, 2. gene clone business, 3. Japanese-derived B cell lines · DNA bank, 4. uman tissue bank, and 5. incurable disease research resource bank. Samples are supplied to Japanese and foreign institutions on demand and sales exceed 100 million Yen/year, but do not cover maintenance expenses

Nikkei Biotech news release, September 16, 2016